Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06229873 · ClinicalTrials.gov registry record · NA
Smartphone App-guided Inspiratory Muscle Strength Training for Lowering Systolic Blood Pressure
A NA study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT06229873: Completed NA study, sponsored by University of Colorado, Boulder.
NCT06229873 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06229873, a NA study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This clinical trial aims to assess the efficacy of inspiratory muscle strength training (IMST) guided by a smartphone app vs. IMST delivered in a clinical research setting for lowering systolic blood pressure in adults 18 years and older with elevated blood pressure. Participants will perform IMST for 5 minutes a day, 6 days a week, for 6 weeks.
Primary Outcome
Change in systolic blood pressure at rest in the clinic setting
Interventions
- DEVICE App-Based Inspiratory Muscle Strength Training
- DEVICE Clinic-Based Inspiratory Muscle Strength Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2024-06-27 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the finished NCT06229873 record still lists
NCT06229873 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which App-Based Inspiratory Muscle Strength Training is the first listed.
NCT06229873 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06229873 about?
NCT06229873 is a clinical study titled "Smartphone App-guided Inspiratory Muscle Strength Training for Lowering Systolic Blood Pressure". This clinical trial aims to assess the efficacy of inspiratory muscle strength training (IMST) guided by a smartphone app vs. IMST delivered in a clinical research setting for lowering systolic blood pressure in adults 18 years and older with elevated blood pressure. Participants will perform IMST f...
What is the current status of trial NCT06229873?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2024-06-27. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT06229873?
The interventions under investigation include: App-Based Inspiratory Muscle Strength Training (DEVICE), Clinic-Based Inspiratory Muscle Strength Training (DEVICE).
Who is sponsoring clinical trial NCT06229873?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06229873's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI